(Q34587424)

3 August 2017

Experience with etanercept in an academic medical center: are infection rates increased? (English)

1 reference

3 August 2017

2

M Elaine Husni

1 reference

3 August 2017

3

Elizabeth W Karlson

1 reference

3 August 2017

Kristine Phillips

1

1 reference

PubMed ID

11932873

3 August 2017

Jonathan S Coblyn

series ordinal

4

1 reference

3 August 2017

1 February 2002

1 reference

3 August 2017

Arthritis & Rheumatology

1 reference

3 August 2017

47

1 reference

3 August 2017

1

1 reference

3 August 2017

17-21

1 reference

Recombinant human tumor necrosis factor receptor (p75) Fc fusion protein (TNFR:Fc) in rheumatoid arthritis

3 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FART1.10243

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10243

Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune re

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10243

The mortality of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10243

Characterization of tumor necrosis factor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10243

Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10243

21 January 2018

Identifiers

DOI

10.1002/ART1.10243

1 reference

3 August 2017

1 reference

PubMed ID

11932873